Kinin receptors in pain and inflammation

European Journal of Pharmacology

Volumn 429, Issue 1-3, 2001, Pages 161-176

  Couture, Réjean ^a   Harrisson, Madelaine ^a   Vianna, Rose Mari ^a   Cloutier, Frank ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Bradykinin; Bradykinin B1 receptor; Bradykinin B2 receptor; Hyperalgesia; Leukocyte; Neurogenic inflammation; Substance P; T lymphocyte

Indexed keywords

1 [N (2 METHOXYBENZYL)ACETYLAMINO] 3 (1H INDOL 3 YL) 2 [N [2 (CYCLOHEXYLPIPERAZIN 1 YL)ACETYL]AMINO]PROPANE; 6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE; AUTACOID; BRADYKININ ANTAGONIST; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR; BRADYKININ RECEPTOR AGONIST; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CYCLOHEXIMIDE; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; ENDOTOXIN; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; KALLIDIN; KALLIKREIN; KININOGEN; LANEPITANT; LY 306740; LYSYL 9 DEARGININE; MITOGEN ACTIVATED PROTEIN KINASE; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RADIOLIGAND; SUBSTANCE P ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BLOOD VESSEL PERMEABILITY; CARBOXY TERMINAL SEQUENCE; CHRONIC PAIN; DIABETES MELLITUS; DRUG EFFECT; HUMAN; HYPERALGESIA; LEUKOCYTE MIGRATION; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MULTIPLE SCLEROSIS; NEUROGENIC INFLAMMATION; NEUTROPHIL; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; TISSUE INJURY; VISCERAL PAIN;

ANIMALS; HUMANS; INFLAMMATION; PAIN; RECEPTORS, BRADYKININ;

EID: 0035840813     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01318-8     Document Type: Review

References (179)

1. Calcitonin gene-related peptides modulate the acute inflammatory response induced by interleukin-1 in the mouse
2. 1 receptors in the polymorphonuclear leukocyte accumulation induced by IL-1β in vivo in the mouse
3. 1 receptors as a new inflammatory target. Could this B the 1?
4. Impaired IL-1β-induced neutrophil accumulation in tachykinin NK1 receptor knockout mice
5. Nonpeptide antagonists for kinin receptors
6. Effect of bradykinin and prostaglandins on the release of calcitonin gene-related peptide-like immunoreactivity from the rat spinal cord in vitro
7. 1 receptor-deficient mice
8. 1 receptor in chinese hamster ovary cells
9. 1 receptor gene for kinins (BDKRB1)
10. 2 receptor antagonist on allergen-evoked exudation and leukocyte infiltration in sensitized rats
11. Inflammatory hyperalgesia induced by zymosan in the plantar tissue of the rat: Effect of kinin receptor antagonists
12. 2 kinin receptor within the plasma membrane of native endothelial cells
13. Antinociceptive activity of the bradykinin antagonist Hoe 140 in rat and mouse
14. Tachykinin and kinin receptor antagonists: Therapeutic perspectives in allergic airway disease
15. Bioregulation of kinins: Kallikreins, kininogens, and kininases
16. Kallikrein and kinin receptor expression in inflammation and cancer
17. Involvement of endogenous kinins in the pathogenesis of peptidoglycan-induced arthritis in the Lewis rat
18. Kinins and kinin receptors: Importance for the activation of leukocytes
19. 2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons
20. 2 bradykinin receptor knockout mice
21. A bradykinin antagonist inhibits carrageenan edema in rats
22. Second messengers involved in the mechanism of action of bradykinin in sensory neurones in culture
23. Kinins in pain and inflammation
24. 1 receptor-mediated vasoactive effects in rabbit synovium
25. Towards understanding the kallikrein-kinin system: Insights from measurement of kinin peptides
26. 2 receptors in bradykinin-induced rat paw oedema
27. 1 receptors mediating paw oedema and formalin induced-nociception. Modulation by glucocorticoids
28. 9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin
29. 2 receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG)
30. 2-receptors mediated rat paw edema by IL-1β and TNFα
31. 1 kinin-receptor upregulation. Evidence for involvement of protein kinases and nuclear factor κB pathways
32. 2 receptors in streptozotocin-diabetic rats
33. The spinal and peripheral roles of bradykinin and prostaglandins in nociceptive processing in the rat
34. 2 receptor agonists in the spinal cord of streptozotocin-diabetic rats
35. Brain sites involved in the antinociceptive effect of bradykinin in rats
36. Brain kallikrein-kinin system: From receptors to neuronal pathways and physiological functions
37. SR142801 behaves as a tachykinin NK-3 receptor agonist on a spinal nociceptive reflex in the rat
38. 1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis
39. Influence of a long-acting bradykinin antagonist, Hoe 140, on some acute inflammatory reactions in the rat
40. 2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat
41. 1 bradykinin receptors and sensory neurones
42. 1 receptor agonist in a non-human primate model: Haemodynamic and pro-inflammatory effects
43. Development of digoxigenin-labeled peptide: Application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues
44. 9]BK: Influence of enalaprilat
45. 9]BK in carrageenan-induced edema
46. Kinins and their receptors in hyperalgesia
47. Bradykinin and inflammatory pain
48. Kinins and pain
49. Activation of a bradykinin receptor in peripheral nerve and spinal cord in the neonatal rat in vitro
50. Bradykinin-induced activation of nociceptors: Receptor and mechanistic studies on the neonatal rat spinal cord-tail preparation in vitro
51. Bradykinin-induced depolarization of primary afferent nerve terminals in the neonatal rat spinal cord in vitro
52. Spatio-temporal pattern of induction of bradykinin receptors and inflammation in rat dorsal root ganglia after unilateral nerve ligation
53. Plasma kinins in synovial exudates
54. Kinins, receptors, kininases and inhibitors - Where did they lead us?
55. 2 kinin receptors to agonist stimulation
56. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia
57. 9-BK in rats pre-treated with LPS
58. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins
59. Sensory neuropeptide release by bradykinin: Mechanisms and pathophysiological implications
60. 9-bradykinin in experimental allergic-encephalomyelitis
61. Possible role of nitric oxide in the antinociceptive action of intraventricular bradykinin in mice
62. 2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction
63. 2 receptor antagonist FR173657 in models of visceral and cutaneous inflammation
64. 2 receptor antagonist FR173657: Inhibition of effects of bradykinin related to its role in nociception
65. Bradykinin is increased during acute and chronic inflammation: Therapeutic implications
66. 1 receptor in a spinal nociceptive reflex in streptozotocin (STZ)-diabetic rats
67. The inhibitory effect of Hoe 140 in mouse abdominal constriction assays
68. 2 receptor is activated by kallikrein and other serine proteases
69. Effects of substance P on functionally identified units in cat spinal cord
70. 2 bradykinin receptors
71. 3-Aryl-1,2-diacetamidopropane derivatives as novel and potent NK-1 receptor antagonists
72. Human monocytes and macrophages express substance P and neurokinin-1 receptor
73. Hoe 140 a new potent and long acting bradykinin-antagonist: In vitro studies
74. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM
75. LY303870, a centrally active neurokinin-1 antagonist with a long duration of action
76. 2 receptor antagonists upon viscero-visceral hyper-reflexia in a rat model of visceral hyperalgesia
77. Intracellular enzymes and kinin enzymes in synovial fluid in joint diseases: Origin and relation to disease category
78. Blood cell dynamics in P-selectin-deficient mice
79. Action of peptides and other algesic agents on paravascular pain receptors of the isolated perfused rabbit ear
80. Influence of neuropeptides on neutrophil adhesion and transmigration through a lung fibroblast barrier in vitro
81. Inflammation modulates the contribution of receptor-subtypes of bradykinin-induced hyperalgesia in the rat
82. Bradykinin stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activity
83. Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma
84. 1-receptor-induced hypotension in the anesthetized dog
85. Bradykinin analogue blocks bradykinin-induced inhibition of a spinal nociceptive reflex in the rat
86. Intrathecal bradykinin acts presynaptically on spinal noradrenergic terminals to produce antinociception in the rat
87. 1 receptors induced by tissue injury
88. Peptides and the primary afferent nociceptor
89. 2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain
90. Cardiovascular responses elicited by intrathecal kinins in the conscious rat
91. Localization of bradykinin-like immunoreactivity in the rat spinal cord: Effects of capsaicin, melittin, dorsal rhizotomy and peripheral axotomy
92. 8]-bradykinin receptor binding sites in the guinea pig spinal cord
93. 8]bradykinin receptor binding sites in the rat spinal cord: Effects of neonatal capsaicin, noradrenergic deafferentation, dorsal rhizotomy and peripheral axotomy
94. Effector mechanisms in low-dose streptozotocin-induced diabetes
95. 1 receptor in peripheral sensory ganglia in the rat
96. Basal and stimulated release of substance P from dissociated cultures of vagal sensory neurons
97. 2 receptors in streptozotocin diabetic rats; involvement in the control of hyperglycemia-induced glomerular MAP kinase activation
98. 2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy
99. 1 receptors for kinins
100. 2 receptor expression in the rabbit
101. Ligand-mediated regulation of kinin receptors in the rabbit
102. 2+ signalling in single cultured vascular smooth muscle cells
103. Substance P induces the expression of an endothelial-leukocyte adhesion molecule by microvascular endothelium
104. Inhibition of interleukinin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-1L-1 receptor monoclonal antibody
105. 1 receptors and the cardiovascular system: Regulation of expression and function
106. 1 receptor expression and leukocyte trafficking across mouse mesenteric postcapillary venules
107. The presence of a kinin in inflammatory synovial effusion from arthritides of varying etiologies
108. 1 bradykinin receptor
109. Receptor-mediated internalization of bradykinin DDT1 MF-2 smooth muscle cells process internalized bradykinin via multiple degradative pathways
110. 2 kinin receptor-mediated internalization of bradykinin in DDT1 MF-2 smooth muscle cells is paralleled by sequestration of the occupied receptors
111. Metabolism of bradykinin in vivo in humans: Identification of BK1-5 as a stable plasma peptide metabolite
112. Substance P induces the expression of intercellular adhesion molecule-1 on vascular endothelial cells and enhances neutrophil transendothelial migration
113. 1 receptor gene in inflammation
114. 1 receptor
115. 2 receptors in the mouse
116. 1) receptors in vivo
117. Isolation and structure of T-kinin
118. Kininogen substrates for trypsin and cathepsin D in human, rabbit and rat plasma
119. 2 kinin receptors by ACE inhibitors in spontaneously hypertensive rat
120. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis
121. Bradykinin stimulates NF-κB activation and interleukin 1β gene expression in cultured human fibroblasts
122. Bradykinin induces eosinophil accumulation in the rat pleural cavity
123. 2 receptor involvement in the antinociceptive effect of bradykinin in rats
124. 1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat
125. 9bradykinin-mediated thermal hyperalgesia in the rat
126. 8]-BK and Hoe 140, in two models of persistent hyperalgesia in the rat
127. 2 receptor mechanisms and cytokine-induced hyperalgesia in the rat
128. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1
129. Endogenous tachykinins play a role in IL-1-induced neutrophil accumulation: Involvement of NK-1 receptors
130. 2 receptors in pulmonary leukocyte accumulation induced by Sephadex beads in guinea pigs
131. 1 receptor gene
132. 1 receptors
133. Plasticity in the expression of bradykinin binding sites in sensory neurons after mechanical nerve injury
134. Interleukinin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint
135. 1 in human lung fibroblasts
136. Kinin receptors in the diabetic mouse
137. 2 receptors, tumour necrosis factor α and inflammatory hyperalgesia
138. 1 receptor expression and function on T lymphocytes in active multiple sclerosis
139. 1 receptor expression and function on human brain endothelial cells
140. The kinin system in rhinitis and asthma
141. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus
142. Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus
143. Evidence that neutrophil accumulation induced by interleukin-1 requires both local protein biosynthesis and neutrophil CD18 antigen expression in vivo
144. 9-bradykinin using a chemiluminescence enzyme immunoassay: Application to its kinetic profile during plasma activation
145. Pharmacology of bradykinin and related kinins
146. 2 subtypes
147. Bradykinin receptors and their antagonists
148. Classification of kinin receptors
149. Antinociceptive action of intraventricular bradykinin
150. Antinociceptive action of bradykinin and related kinins of larger molecular weights by the intraventricular route
151. 2 receptor on nociception in rats and mice
152. Pro-inflammatory effects induced by bradykinin in a murine model of pleurisy
153. 1 receptor up-regulation in human umbilical vein
154. Bradykinin stimulates alveolar macrophages to release neutrophil, monocyte, and eosinophil chemotactic activity
155. 1-receptor in cultured human lung fibroblasts
156. 1-receptor localisation along the rat nephron
157. 1 bradykinin receptors and carboxypeptidase M are both upregulated in the aorta of pigs after LPS infusion
158. 2 receptor knockout mice
159. Concentration-dependent effects of bradykinin on leukocyte recruitment and venular hemodynamics in rat mesentery
160. 1 kinin receptor activity in pigs is associated with pre-existing infection
161. Bradykinin down-regulates LPS-induced eosinophil accumulation in the pleural cavity of mice through type 2-kinin receptor activation: A role for prostaglandins
162. Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin
163. Bradykinin as a pain mediator: Receptors are localized to sensory neurons, and antagonists have analgesic actions
164. Metabolism-resistant bradykinin antagonists: Development and applications
165. 2 receptor antagonists in rats
166. CGRP stimulates the adhesion of leukocytes to vascular endothelial cells
167. Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages
168. Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system
169. 2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture
170. 9-BK in mouse pleurisy
171. 1 receptor induces pleurisy in streptozotocin (STZ)-diabetic rats
172. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
173. 1 receptor antagonist
174. The bradykinin antagonist Hoe 140 inhibits carrageenan and thermically induced paw oedema in rats
175. 1 receptor is constitutively expressed in the rat sensory nervous system
176. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells
177. 1 receptor gene expression
178. 2 kinin receptor antagonists in diabetic mice
179. The involvement of kallikrein-kinin system in diabetes type I (insulitis)